Arrakis Therapeutics Stock

arrakistx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $113.5MM

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.

Register To Buy and Sell Shares

For more details on financing and valuation for Arrakis Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Arrakis Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Arrakis Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Daniel Koerwer
Chief Business Officer
Heather Lounsbury
Vice President of Business & Technical Operations
Jennifer Petter Ph.D
Co-Founder & Chief Scientific Officer
Rajesh Parekh Ph.D
Co-Founder & Board Member
Michael Gilman Ph.D
Chief Executive Officer & Chairman
Alan Walts Ph.D
Co-Founder & Board Member
James Barsoum Ph.D
Senior Vice President of Biology
Henri Termeer

Board Members

Carolyn Green
Matthew Cohen Ph.D
Osage Venture Partners
Rajesh Parekh Ph.D
Alan Walts Ph.D
Jakob Loven Ph.D
Nextech Invest
Nikola Trbovic Ph.D
Pfizer Ventures
Colleen Cuffaro Ph.D
Canaan Partners
Elaine Jones Ph.D
Pfizer Ventures
Peter Worland Ph.D
Richard Gaster MD
Michael Gilman Ph.D
Timothy Shannon MD
Canaan Partners

Frequently Asked Questions About Arrakis Therapeutics’ Stock

Can you buy Arrakis Therapeutics’ stock?
Arrakis Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Arrakis Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Arrakis Therapeutics’ stock?
Yes, you can sell stock of a private company like Arrakis Therapeutics. Forge can help you sell your Arrakis Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Arrakis Therapeutics’ stock price?
Arrakis Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Arrakis Therapeutics’ private market stock price with Forge Data.
What is Arrakis Therapeutics’ stock ticker symbol?
Arrakis Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Arrakis Therapeutics : Appoints Katrine Bosley as Chairman of the Board of Directors
Arrakis Therapeutics Appoints Elizabeth Radcliffe as Vice President of Finance and Strategy
Arrakis Therapeutics appoints Elizabeth Radcliffe as Vice President of Finance and Strategy.
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.